TheraCryf Plc (TCF) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Jul 2024 03:02 PM
RNS
Result of AGM
17 Jul 2024 10:26 AM
RNS
Holding(s) in Company
16 Jul 2024 12:50 PM
RNS
Holding(s) in Company
10 Jul 2024 02:00 PM
RNS
Publication of peer-reviewed data on SFX-01
21 Jun 2024 09:00 AM
RNS
Annual Financial Report and Notice of AGM
13 Jun 2024 03:14 PM
RNS
Holding(s) in Company
13 Jun 2024 07:00 AM
RNS
TheraCryf Research and Development Day
04 Jun 2024 03:04 PM
RNS
Holding(s) in Company
28 May 2024 04:05 PM
RNS
Final Results - Correction
28 May 2024 07:00 AM
RNS
Final Results
22 May 2024 07:00 AM
RNS
Notice of R&D presentation
20 May 2024 07:00 AM
RNS
Notice of Results
02 May 2024 10:47 AM
RNS
Holding(s) in Company
02 May 2024 07:00 AM
RNS
Chronos Integration Update
02 May 2024 07:00 AM
RNS
Total Voting Rights
25 Apr 2024 03:46 PM
RNS
Change of Name
22 Apr 2024 10:11 AM
RNS
Holding(s) in Company
11 Apr 2024 03:04 PM
RNS
Holding(s) in Company
09 Apr 2024 07:00 AM
RNS
Holding(s) in Company
08 Apr 2024 04:03 PM
RNS
Holding(s) in Company
05 Apr 2024 03:39 PM
RNS
Director/PDMR Shareholding
05 Apr 2024 02:40 PM
RNS
Holding(s) in Company
04 Apr 2024 01:59 PM
RNS
Result of General Meeting
04 Apr 2024 07:00 AM
RNS
Result of Retail Offer
19 Mar 2024 05:03 PM
RNS
Retail Offer
19 Mar 2024 05:00 PM
RNS
Acquisition, Fundraising and Change of Name
27 Feb 2024 07:00 AM
RNS
SFX-01 positive update in bowel cancer models
19 Feb 2024 11:22 AM
RNS
Positive update on SFX-01 in vitro GBM studies
09 Feb 2024 11:01 AM
RNS
Notice of Dispute lodged with Stalicla SA
16 Jan 2024 03:07 PM
RNS
Series B Fund Raise by partner, Stalicla SA
29 Dec 2023 11:29 AM
RNS
Holding(s) in Company
22 Dec 2023 07:00 AM
RNS
Directorate Changes
13 Nov 2023 07:00 AM
RNS
Upcoming conferences
31 Oct 2023 07:00 AM
RNS
Half-year Report
26 Oct 2023 07:00 AM
RNS
Erasmus Medical Center begins glioblastoma studies
19 Oct 2023 02:26 PM
RNS
Authored Article Publication
05 Sep 2023 07:00 AM
RNS
Directorate Changes
15 Aug 2023 07:00 AM
RNS
Final Report from Phase 1b PK/PD study
03 Aug 2023 12:38 PM
RNS
Rule 17 Disclosure
02 Aug 2023 07:00 AM
RNS
Return of rights to Sulforadex from Juvenescence
21 Jul 2023 12:02 PM
RNS
Result of AGM
27 Jun 2023 07:00 AM
RNS
SFX-01 radiosensitisation effect confirmed in-vivo
20 Jun 2023 01:59 PM
RNS
Notice of AGM & Posting of Annual Report
19 Jun 2023 07:00 AM
RNS
Grant Success for Glioblastoma studies
07 Jun 2023 07:00 AM
RNS
Final Results
26 May 2023 11:00 AM
RNS
Notice of Results
01 May 2023 07:59 PM
BZW
Distribution Dates and Amounts Announced for ...
22 Mar 2023 07:00 AM
RNS
Preliminary results from Phase 1b study
16 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
16 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
UK 100

Latest directors dealings